Company Analysis Chemed Corporation
1. Summary
Advantages
- The stock's return over the last year (-1.36%) is higher than the sector average (-26.12%).
- Current debt level 8.81% is below 100% and has decreased over 5 years from 9.14%.
- The company's current efficiency (ROE=24.6%) is higher than the sector average (ROE=-80.94%)
Disadvantages
- Price (539.48 $) is higher than fair price (207.74 $)
- Dividends (0.2798%) are below the sector average (1.24%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Chemed Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | -6.6% | 2.3% | 1.2% |
| 90 days | 0.4% | -36.1% | 6.6% |
| 1 year | -1.4% | -26.1% | 31.7% |
CHE vs Sector: Chemed Corporation has outperformed the "Healthcare" sector by 24.76% over the past year.
CHE vs Market: Chemed Corporation has significantly underperformed the market by -33.01% over the past year.
Stable price: CHE is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CHE with weekly volatility of -0.0262% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (539.48 $) is higher than the fair price (207.74 $).
Price is higher than fair: The current price (539.48 $) is 61.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (33.08) is lower than that of the sector as a whole (57.99).
P/E vs Market: The company's P/E (33.08) is lower than that of the market as a whole (47.41).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.14) is lower than that of the sector as a whole (9.41).
P/BV vs Market: The company's P/BV (8.14) is lower than that of the market as a whole (22.54).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.98) is lower than that of the sector as a whole (4.07).
P/S vs Market: The company's P/S indicator (3.98) is lower than that of the market as a whole (15.1).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (22.06) is higher than that of the sector as a whole (17.44).
EV/Ebitda vs Market: The company's EV/Ebitda (22.06) is higher than that of the market as a whole (22.02).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 4.77% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (4.77%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-14.25%).
5.4. ROE
ROE vs Sector: The company's ROE (24.6%) is higher than that of the sector as a whole (-80.94%).
ROE vs Market: The company's ROE (24.6%) is higher than that of the market as a whole (16.9%).
5.5. ROA
ROA vs Sector: The company's ROA (15.48%) is higher than that of the sector as a whole (6.66%).
ROA vs Market: The company's ROA (15.48%) is higher than that of the market as a whole (6.57%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (26.88%) is higher than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (26.88%) is higher than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.2798% is below the average for the sector '1.24%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.2798% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 0.2798% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (8.62%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 01.08.2024 | HUTTON THOMAS C Director |
Purchase | 554.39 | 2 676 040 | 4 827 |
| 12.06.2024 | GRACE PATRICK P Director |
Sale | 540.98 | 153 638 | 284 |
| 06.06.2024 | MCNAMARA KEVIN J president and CEO |
Sale | 544.17 | 816 255 | 1 500 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
